DIABETIC DYSLIPIDEMIA AND ATHEROSCLEROSIS

被引:0
|
作者
SHEPHERD, J
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Non insulin-dependent diabetes mellitus is frequently accompanied by qualitative and quantitative abnormalities in plasma lipids and lipoproteins, Increased triglycerides and decreased HDL (high density lipoprotein)-cholesterol are commonly observed; these alterations are recognized risk factors for coronary heart disease. Moderately elevated plasma triglyceride-rich liproproteins may contribute to the atherogenic process through remodelling of LDL (low density liproprotein) and HDL particles. Good glycemic control, diet and, when necessary, treatment with fibrates will correct or partially reverse the abnormal lipoprotein profiles found in diabetic patients.
引用
收藏
页码:1933 / 1937
页数:5
相关论文
共 50 条
  • [41] Chronic Kidney Disease, Dyslipidemia, and Atherosclerosis
    Shoji, Tetsuo
    Abe, Takaaki
    Matsuo, Hiroshi
    Egusa, Genshi
    Yamasaki, Yoshimitsu
    Kashihara, Naoki
    Shirai, Kohji
    Kashiwagi, Atsunori
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (04) : 299 - 315
  • [42] DYSLIPIDEMIA REGISTRY OF THE SPANISH ATHEROSCLEROSIS SOCIETY
    Perez-Calahorra, S.
    Lahoz, C.
    Plana, N.
    Errasti-Amiano, U.
    Climent, E.
    Elias Sanchez, T.
    Puzo, J.
    Zabala, S.
    Mateo-Gallego, R.
    Ros, E.
    Civeira, F.
    ATHEROSCLEROSIS, 2014, 235 (02) : E199 - E199
  • [43] Coronary distensibility is impaired in diabetic dyslipidemia before overt atherosclerosis and segmental variation is identifiable by intravascular ultrasound
    Zafar, MN
    Reddy, HK
    Mokelke, E
    Sturek, M
    CIRCULATION, 2003, 108 (17) : 463 - 463
  • [44] Atherogenic dyslipidemia and diabetic nephropathy
    Giuseppina Russo
    Pamela Piscitelli
    Annalisa Giandalia
    Francesca Viazzi
    Roberto Pontremoli
    Paola Fioretto
    Salvatore De Cosmo
    Journal of Nephrology, 2020, 33 : 1001 - 1008
  • [45] Diabetic dyslipidemia and its therapy
    Garg, A
    Grundy, SM
    DIABETES REVIEWS, 1997, 5 (04): : 425 - 433
  • [46] Diabetic dyslipidemia: evaluation and mechanism
    Yanai, Hidekatsu
    Hirowatari, Yuji
    Yoshida, Hiroshi
    GLOBAL HEALTH & MEDICINE, 2019, 1 (01): : 30 - 35
  • [47] Pharmacological management of diabetic dyslipidemia
    Filippatos, T. D.
    Florentin, M.
    Georgoula, M.
    Elisaf, M. S.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (02) : 187 - 200
  • [48] Creation of diabetic dyslipidemia in in mice
    Kako, Y
    Masse, M
    Tall, AR
    Goldberg, IJ
    DIABETES, 2000, 49 : A13 - A13
  • [49] Diabetic dyslipidemia: beyond LDL
    Merkel, M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 (20) : 1067 - 1073
  • [50] Diabetic dyslipidemia or 'diabetes lipidus'?
    Muacevic-Katanec, Diana
    Reiner, Zeljko
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2011, 9 (03) : 341 - 348